Insights into neurodevelopmental features of Huntington's disease from stem cell-derived models including organoids. [PDF]
Sierra M +3 more
europepmc +1 more source
Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders. [PDF]
Pereira Sena P +9 more
europepmc +1 more source
Analysis of short tandem repeats linked to polyglutamine diseases from whole-genome sequencing reveals intermediate alleles of <i>HTT</i> associated with an early disease onset in <i>C9orf72</i> carriers. [PDF]
Barbier M +24 more
europepmc +1 more source
Revisiting the clastosome: a stress-induced nuclear proteolytic compartment of mammalian cells. [PDF]
Lafarga M +4 more
europepmc +1 more source
Biomarkers in Spinocerebellar Ataxias. [PDF]
Klockgether T, Grobe-Einsler M, Faber J.
europepmc +1 more source
Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease. [PDF]
Ishtayeh H +11 more
europepmc +1 more source
Retrotransposition Events Shape the Evolution of the Ataxin-3 Gene Family in Primates. [PDF]
Felício D +7 more
europepmc +1 more source
Familial spinocerebellar ataxia type 3: A case report of multi-generational presentation. [PDF]
Wang J +7 more
europepmc +1 more source
Electrical silencing of dendritic arborization neurons rescues toxic polyglutamine-induced locomotion defect. [PDF]
Miao H, Kim WJ.
europepmc +1 more source
PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. [PDF]
Sangotra A +7 more
europepmc +1 more source

